Bay Street News, January, 2024

NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) — Aquaron Acquisition Corp. (NASDAQ: AQU, the “Company”), a special purpose acquisition company, […]

WATERTOWN, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, […]

TORONTO and MELBOURNE, Australia, Jan. 03, 2024 (GLOBE NEWSWIRE) — Banxa Holdings Inc. (TSXV: BNXA) (OTCQX: BNXAF) (FSE: AC00) (“Banxa” or […]

RALEIGH, N.C., Jan. 03, 2024 (GLOBE NEWSWIRE) — Enact Holdings, Inc. (Nasdaq: ACT) (Enact), a leading provider of private mortgage […]

MIAMI, Jan. 03, 2024 (GLOBE NEWSWIRE) — Vision Sensing Acquisition Corp. (NASDAQ: VSACU, VSAC, VSACW) (the “Company”) a special purpose […]

– On track to report interim Phase 1 data for VG-3927 in healthy volunteers in mid-2024 and Phase 2 results […]

CONSHOHOCKEN, Pa., Jan. 03, 2024 (GLOBE NEWSWIRE) — Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a clinical-stage biopharmaceutical company pursuing novel therapeutics […]

THE WOODLANDS, Texas, Jan. 03, 2024 (GLOBE NEWSWIRE) — ChampionX Corporation (“ChampionX” or the “Company”) (NASDAQ: CHX) announced today that […]

Hong Kong, Jan. 03, 2024 (GLOBE NEWSWIRE) — Fenbo Holdings Limited (the “Company” or “Fenbo”), an established provider of personal […]

PALO ALTO, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage […]